Microbiology: Current Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Influenza vaccination of patients with autoimmune rheumatic disease

4th International Conference on Medical Microbiology
May 20-21, 2019 | Vienna, Austria

Stojanovich L

University Medical Center Bezanijska kosa, Serbia

Posters & Accepted Abstracts : Microbiol Curr Res


Objectives: Compared to the healthy population, patients suffering from autoimmune rheumatic diseases have a significantly increased risk of various infections.

Methods: Our study includes three groups of patients (99 in total) with stable diseases status, suffering from: 30 patients with systemic lupus erythematosus (SLE), 37 with rheumatoid arthritis (RA) and 32 with Sjögren's Syndrome (SjS). 46 patients were immunized with an inactivated trivalent split vaccine (15 μg HA A/California/7/2009 (H1N1), 15 μg HA A/ Pert/16/2009 (H3N2) and 15 μg / HA B Brisbane / 60/2008) whereas 52 patients did not accept the proposed vaccination. These three groups of patients were divided into two subgroups depending on vaccination: Vaccinated - SLE1 (19), RA1 (15) and SjS1 (14), and unvaccinated - SLE2 (11), RA2 (22), SjS2 (18). In the following six months parameters of disease activity and the titer of antibodies against influenza A H1N1 were monitored. We used hemagglutination inhibition test (according to the method of the Center for Disease Control and Prevention (CDC) with antigen A/California/7/2009 influenza virus (H1N1), and turkey erythrocytes for the detection of antibodies against the A H1N1.

Results: The incidence of viral and bacterial infections among vaccinated patients was significantly lower, compared to the non-vaccinated group. Influenza occurrence was significantly associated with previous respiratory infections (p=0.001). ST levels for all vaccinated patients (84.17) were significantly higher than in non-vaccinated patients (8.80) (p=0.008) and were associated with last vaccination in all patients and in SLE group (p=0.012, p=0.039 respectively). Seroprotective rate for all vaccinated patients was 48% compared to 15% in unvaccinated (p=0.014) and it was highest among SLE patients (53%) (p= 0.049).

Conclusions: Based on several years of monitoring respiratory infections in our patients, it is clearly visible that a high risk for exacerbation of the underlying disease was linked to viral or bacterial infection and practically never to the vaccination itself.




Get the App